1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

TNDM
Tandem Diabetes Care, Inc.US flagNASDAQ Global Market
19.90
USD
-0.53
- -
1.36BMarket Cap

Total Valuation

Tandem Diabetes Care, Inc. carries a market capitalization of 1.36B, placing it among publicly traded companies globally. Its enterprise value stands at 1.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.36B
Enterprise Value1.33B

Share Statistics

Tandem Diabetes Care, Inc. currently has 69.54M shares outstanding.

Shares Outstanding69.54M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.99, and the price-to-book ratio stands at 8.05.

PE RatioN/A
PS Ratio0.99
PB Ratio8.05
P/TBV Ratio8.05
P/FCF Ratio20.32
P/OCF Ratio-186.52

Enterprise Valuation

EV / Sales1.28
EV / EBITDAN/A
EV / EBITN/A
EV / FCF23.26

Financial Position

Tandem Diabetes Care, Inc. maintains a current ratio of 3.18, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 566.96, indicating elevated leverage, while an interest coverage ratio of -4.38 demonstrates limited ability to service its debt obligations.

Current Ratio3.18
Quick Ratio2.44
Debt / Equity566.96
Debt / EBITDA-26.56
Interest Coverage-4.38

Financial Efficiency

Return on Equity (ROE)-48.03
Return on Assets (ROA)-6.24
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-19.86
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.30

Taxes

Over the trailing twelve months, Tandem Diabetes Care, Inc. has paid 2.32M in income taxes, reflecting an effective tax rate of 112.58.

Income Tax2.32M
Effective Tax Rate112.58

Stock Price Statistics

Tandem Diabetes Care, Inc.'s stock has gained approximately 59.2% over the past 52 weeks. The 50-day moving average sits at 19.14, while the 200-day moving average is 19.78.

Beta (5Y)N/A
52-Week Price Change59.2%
50-Day Moving Average19.14
200-Day Moving Average19.78
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Tandem Diabetes Care, Inc. generated 1.04B in revenue and converted that into -63.31M in net income, yielding earnings per share of -0.93. EBITDA reached -27.83M, while operating income came in at -45.79M.

Revenue1.04B
Gross Profit583.32M
Operating Income-45.79M
Pretax Income-61.00M
Net Income-63.31M
EBITDA-27.83M
EBIT-45.79M
Earnings Per Share (EPS)-0.93

Balance Sheet

Tandem Diabetes Care, Inc. holds 456.00M in cash and equivalents against 739.25M in total debt, resulting in a net debt position of 539.76M. Total book value stands at 130.39M, with working capital of 551.63M providing operational flexibility.

Cash & Cash Equivalents456.00M
Total Debt739.25M
Net Debt539.76M
Equity (Book Value)130.39M
Book Value Per Share1.88
Working Capital551.63M

Cash Flow

Tandem Diabetes Care, Inc. produced -5.52M in operating cash flow over the past twelve months. After subtracting -56.22M in capital expenditures, free cash flow totaled -61.74M - equivalent to -0.90 per share.

Operating Cash Flow-5.52M
Capital Expenditures-56.22M
Free Cash Flow-61.74M
FCF Per Share-0.90

Margins

Tandem Diabetes Care, Inc. operates with a gross margin of 56.01, reflecting its pricing power and cost economics. The operating margin of -4.40 and net profit margin of -6.08 provide insight into operational efficiency.

Gross Margin56.01
Operating Margin-4.40
Pretax Margin-5.86
Profit Margin-6.08
EBITDA Margin-2.67

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-26.43
FCF Yield4.92

Stock Splits

Tandem Diabetes Care, Inc.'s most recent stock split took place on October 10, 2017 with a 10:1 split ratio.

Last Split Date10/10/2017
Split Ratio10:1

Scores

Tandem Diabetes Care, Inc. posts an Altman Z-Score of 0.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.39